Liver transplantation for patients with lamivudine-resistant HBV: what is the optimal prophylactic strategy?

  • Anna S. F. Lok
  • Published 2005 in
    Liver transplantation : official publication of…

Abstract

The use of hepatitis B immune globulins (HBIG) revolutionized liver transplantation for hepatitis B. In the landmark paper by Samuel et al. in 1993, recurrence of hepatitis B virus (HBV) infection 3 years after liver transplantation was reduced from 75% in patients who received no HBIG to 36% in those who received HBIG for at least 6 months.1 However, the… (More)

1 Figure or Table

Topics

  • Presentations referencing similar topics